Form D · Biotechnology
DJIT MEDTECH, INC.
Baltimore, MD · CIK 0001990885
Offering snapshot reported Aug 23, 2023 · SEC filing
- Reported sold
- $140K Offering amount: $150K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 1, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 23, 2023 | Initial | $140,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-490529
Simple Agreement for Future Equity
Source: Form D, filed Aug 23, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marcia A. Hart | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1628 Bolton Street
Baltimore, MD, 21217
Baltimore, MD, 21217